ABCB1 and colorectal cancer: A current study suggested that overexpression of IGF2BP3 in HCT8/T cell bound to the m6A site of ABCB1 and elevated ABCB1 expression, thereby reducing the sensitivity of colorectal cancer (CRC) cells to chemotherapy [60].